Beita PharmaTech is Biotechnology in China that focus on detection research business. Founded in 2008. They cover business area such as developer, isotope-label precursor compound, small pharmaceutical molecule, biologically active small molecule, pharmacokinetic, clinical and disease detection research, isotope labeling, customize service, analysis, separation technology.
2008
( 16 years old in 2024 )
Detection Research
-
Building C7, No. 6 Dongsheng West Road
Jiangyin, Jiangsu 214437
China
Private
developerisotope-label precursor compoundsmall pharmaceutical moleculebiologically active small moleculepharmacokineticclinical and disease detection researchisotope labelingcustomize serviceanalysisseparation technology
* We use standard office opening hours in near Beita PharmaTech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Beita PharmaTech is Biotechnology business from China that founded in 2008 (16 years old in 2024), Beita PharmaTech business is focusing on Detection Research.
Beita PharmaTech headquarter office and corporate office address is located in Building C7, No. 6 Dongsheng West Road Jiangyin, Jiangsu 214437 China.
Beita PharmaTech was founded in China.
In 2024, Beita PharmaTech is currently focus on detection research sector.
Above is snippet of Google Trends for "detection research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Beita PharmaTech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
